Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth

TOPALOĞLU R. , GÜLHAN B. , Celegen K., Inozu M., Hayran M. , Duzoya A. , ...Daha Fazla

FRONTIERS IN PEDIATRICS, cilt.7, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background: Since the early 2000s rituximab (RTX) has been thought of as an alternative treatment for steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS).